[Increase of cerebral dopamine levels by alpha-chymotrypsin in rats pretreated with oxypertine and L-dopa].
D000818:Animals; D001812:Blood-Brain Barrier; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002918:Chymotrypsin / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism*; D005260:Female; D007211:Indoles / Q000494:pharmacology*; D007980:Levodopa / Q000494:pharmacology*; D008297:Male; D009638:Norepinephrine / Q000032:analysis; D010879:Piperazines / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000032:analysis
D007211:Indoles; D010879:Piperazines; D012701:Serotonin; D007980:Levodopa; D012110:Reserpine; D002918:Chymotrypsin; D004298:Dopamine; D009638:Norepinephrine
Elévation par l'alpha-chymotrypsine de la concentration cérébrale en dopamine chez le rat soumis à l'oxypertine et à la l dopa